EcoDrugPlus

Ensembl ID : ENSOJAG00000004798
Gene Symbol: RPL24
1 Cross references
318 Possible Orthologues:

Ensembl ID : ENSOJAG00000005815
Gene Symbol: -
Cross references: -
431 Possible Orthologues:

Ensembl ID : ENSOJAG00000004529
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOJAG00000005902
Gene Symbol: VDRB
1 Cross references
392 Possible Orthologues:

Ensembl ID : ENSOJAG00000006008
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOJAG00000014369
Gene Symbol: PSMD11B
1 Cross references
220 Possible Orthologues:

Ensembl ID : ENSOJAG00000006111
Gene Symbol: -
Cross references: -
431 Possible Orthologues:

Ensembl ID : ENSOJAG00000004354
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOJAG00000013084
Gene Symbol: RPL34
1 Cross references
362 Possible Orthologues:

Ensembl ID : ENSOJAG00000004339
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOJAG00000006660
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOJAG00000012953
Gene Symbol: RPL35
1 Cross references
274 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).